Persistence of autoantibodies directed against the beta-1-adrenoceptor in patients with heart failure after treatment with BC 007 (Rovunaptabin). Results of a phase IIa study.
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
University Hospital Medical Center Bezanijska Kosa, Belgrade (Serbia)
7 More presentations in this session
Miss H. Hauksdottir (Reykjavik, IS)
Doctor S. Zhou (Toronto, CA)
Doctor I. Isaia (Rochester, US)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
